Last reviewed · How we verify

Resuscitation (Saline) — Competitive Intelligence Brief

Resuscitation (Saline) (Resuscitation (Saline)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid / Electrolyte replacement. Area: Critical Care / Emergency Medicine.

phase 3 Crystalloid fluid / Electrolyte replacement Critical Care / Emergency Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Resuscitation (Saline) (Resuscitation (Saline)) — Universidad Nacional de La Plata. Saline resuscitation restores circulating blood volume and tissue perfusion by administering isotonic sodium chloride solution intravenously.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Resuscitation (Saline) TARGET Resuscitation (Saline) Universidad Nacional de La Plata phase 3 Crystalloid fluid / Electrolyte replacement
Sterile isotonic saline solution Sterile isotonic saline solution Hospital Italiano de Buenos Aires marketed Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride 0.9% infusion Sodium Chloride 0.9% infusion Hospital Central "Dr. Ignacio Morones Prieto" marketed Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride [0.9%] Sodium Chloride [0.9%] Fundacion Clinica Valle del Lili marketed Crystalloid fluid / Electrolyte replacement
Sodium Chloride 0.9% Inj Sodium Chloride 0.9% Inj Dalarna County Council, Sweden marketed Crystalloid fluid / Electrolyte replacement
Isotonic sodium chloride 0.9 percent Isotonic sodium chloride 0.9 percent Rigshospitalet, Denmark marketed Crystalloid fluid / Electrolyte replacement solution
saline 09% saline 09% Vinmec Healthcare System marketed Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid / Electrolyte replacement class)

  1. University of Auckland, New Zealand · 2 drugs in this class
  2. Fundacion Clinica Valle del Lili · 1 drug in this class
  3. Montefiore Medical Center · 1 drug in this class
  4. Rhode Island Hospital · 1 drug in this class
  5. Rigshospitalet, Denmark · 1 drug in this class
  6. Seoul National University Hospital · 1 drug in this class
  7. Universidad Nacional de La Plata · 1 drug in this class
  8. University of Nottingham · 1 drug in this class
  9. Dalarna County Council, Sweden · 1 drug in this class
  10. Université du Québec à Trois-Rivières · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Resuscitation (Saline) — Competitive Intelligence Brief. https://druglandscape.com/ci/resuscitation-saline. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing